Document is current
Any future updates will be listed below
-
Authors
Ou, Hui-Ling https://orcid.org/0009-0001-9162-9642
Hoffmann, Reuben
Smith, Rebecca
Devlin, Kaylyn https://orcid.org/0000-0001-5842-0591
Dane, Mark
Muñoz-Espín, Daniel https://orcid.org/0000-0002-0550-9514
Korkola, James E. https://orcid.org/0000-0002-0030-6216
- License Information
-
More Information
Article History
Received: 9 January 2026
Revised: 9 September 2026
Accepted: 14 September 2026
First Online: 5 October 2026
Ethics
Competing interests: JEK is a co-founder and stockholder in Convergent Genomics. The work described in this manuscript is not related to any work being performed at Convergent Genomics. DME is involved in Senesys. Bio spin off company working on the development of a new generation of senolytics but none of the work described in the manuscript is related to the use of those senolytics. The other authors have stated that they have no conflicts of interest in connection with this article.
